依西酞普兰
中止
抗抑郁药
医学
萧条(经济学)
内科学
麻醉
心理学
儿科
宏观经济学
经济
海马体
作者
Norio Yasui‐Furukori,Kojiro Hashimoto,Shoko Tsuchimine,Tetsu Tomita,Norio Sugawara,Masamichi Ishioka,Kazuhiko Nakamura
标识
DOI:10.1097/wnf.0000000000000139
摘要
These findings suggest that a higher dose and lower clearance of escitalopram lead to a higher risk of ADS. Very slow tapering is recommended for all patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI